Celgene might buy CAR-T biotech Juno Therapeutics
January 17, 2018 at 09:25 AM EST
Juno is one of several companies pioneering a cancer treatment called CAR-T, which is new and very promising.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|